Ryan, C. P. https://orcid.org/0000-0002-0550-7949
Corcoran, D. L.
Banskota, N.
Eckstein Indik, C.
Floratos, A.
Friedman, R.
Kobor, M. S.
Kraus, V. B. https://orcid.org/0000-0001-8173-8258
Kraus, W. E. https://orcid.org/0000-0003-1930-9684
MacIsaac, J. L.
Orenduff, M. C.
Pieper, C. F.
White, J. P. https://orcid.org/0000-0003-2667-0806
Ferrucci, L. https://orcid.org/0000-0002-6273-1613
Horvath, S. https://orcid.org/0000-0002-4110-3589
Huffman, K. M.
Belsky, D. W. https://orcid.org/0000-0001-5463-2212
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG061378, R01AG054840, R33AG070455, U01AG060908, R33AG070455)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P30CA013696)
Article History
Received: 14 May 2024
Accepted: 4 November 2024
First Online: 13 December 2024
Competing interests
: D.W.B. and D.L.C. are listed as inventors of the Duke University and University of Otago invention DunedinPACE, which is licensed to TruDiagnostic. D.W.B. is consulting CSO and SAB chair of BellSant and serves on the SAB of the Hooke Clinic. The Regents of the University of California are the sole owner of patents and patent applications directed at epigenetic biomarkers for which S.H. is a named inventor; S.H. is a founder and paid consultant of the non-profit Epigenetic Clock Development Foundation that licenses these patents. S.H. is a Principal Investigator at the Altos Labs, Cambridge Institute of Science, a biomedical company that works on rejuvenation. The remaining authors declare no competing interests.